New insights on possible vaccine development against SARS-CoV-2

In December 2019, a novel virus, namely COVID-19 caused by SARS-CoV-2, developed from Wuhan, (Hubei territory of China) used its viral spike glycoprotein receptor-binding domain (RBD) for the entrance into a host cell by binding with ACE-2 receptor and cause acute respiratory distress syndrome (ARDS...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaudhry, Sundas Nasir, Hazafa, Abu, Mumtaz, Muhummad, Kalsoom, Ume, Abbas, Saima, Kainaat, Amna, Bilal, Shahid, Zafar, Nauman, Siddique, Aleena, Zafar, Ayesha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484811/
https://www.ncbi.nlm.nih.gov/pubmed/32926920
http://dx.doi.org/10.1016/j.lfs.2020.118421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484811/
https://www.ncbi.nlm.nih.gov/pubmed/32926920
http://dx.doi.org/10.1016/j.lfs.2020.118421

Ejemplares similares